Search

everythinglearnresearchcommunity

for

Search:↓

People with autism are more likely to develop alopecia areata than those without autism.

Alopecia areata in elderly people is usually mild and responds well to treatment.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Thyroid function may influence hair loss after COVID-19.

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

RDW can be a useful marker for inflammation in alopecia areata patients.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Low levels of vitamin B12 and ferritin are linked to early hair graying.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

Older men's scalp damage increases with age and sun exposure, a baby girl in the Philippines has Schimmelpenning syndrome, and thyroid screening is advised for children with hair loss and certain risk factors.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

People with alopecia areata often have abnormal thyroid hormones, thyroid antibodies, antinuclear antibodies, low vitamin D, and high C-reactive protein levels.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Many children with alopecia areata also have other autoimmune diseases.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.